U.S. federal trademark · Serial No. 78281011
Process by which antibodies are utilized to identify, or "target" immunogenic materials that may then be used to develop therapies
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.